Role of Liver-Mediated Tolerance in Nanoparticle-Based Tumor Therapy
In the last decades, the use of nanocarriers for immunotherapeutic purposes has gained a lot of attention, especially in the field of tumor therapy. However, most types of nanocarriers accumulate strongly in the liver after systemic application. Due to the default tolerance-promoting role of liver n...
Main Authors: | Maximiliano L. Cacicedo, Carolina Medina-Montano, Leonard Kaps, Cinja Kappel, Stephan Gehring, Matthias Bros |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/9/1985 |
Similar Items
-
Nitric oxide in liver fibrosis: The role of inducible nitric oxide synthase
by: Yasuko Iwakiri
Published: (2015-12-01) -
Role of hepatic stellate cells in liver ischemia-reperfusion injury
by: Yuming Peng, et al.
Published: (2022-07-01) -
Kupffer Cells as a Target for Immunotherapy
by: Takashi Sakai, et al.
Published: (2022-12-01) -
Integrative Analysis of RNA Expression and Regulatory Networks in Mice Liver Infected by Echinococcus multilocularis
by: Tingli Liu, et al.
Published: (2022-03-01) -
α2-Adrenergic Receptor in Liver Fibrosis: Implications for the Adrenoblocker Mesedin
by: Ute A. Schwinghammer, et al.
Published: (2020-02-01)